Journals / Nöropsikiyatri Arşivi / 2008 / Cilt: 45 - Sayı: 3

Neropsychiatric aspects of systemic lupus erythematosus in children and adolescents

Çocuk ve ergenlerde sistemik lupus eritematosus’un nöropsikiyatrik görünümleri

Pages
92–96
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The primary physician should consult with a child psychiatrist when psychiatric symptoms are seen in terms of the differential diagnosis and treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Systemic lupus erythematosus (SLE) is an autoimmune multisystemic disease, and the central nervous system is one of the most common major systems to be involved .
📊
Key Findings & Data:SLE patients having neurologic involvement were found to experience neuropsychiatric complications such as psychosis, seizures and various cognitive dysfunctions.
💡
Conclusion & Impact:The primary physician should consult with a child psychiatrist when psychiatric symptoms are seen in terms of the differential diagnosis and treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Lupus eritematozus · sistemik · Tanı

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune multisystemic disease, and the central nervous system is one of the most common major systems to be involved . SLE patients having neurologic involvement were found to experience neuropsychiatric complications such as psychosis, seizures and various cognitive dysfunctions. Neuropsychiatric SLE (NP-SLE) can cause any form of affective illness. Psychiatric involvement can include mood lability, unusual elation, irritability and depression or psychosis. Diagnosis is difficult to make owing to the wide variety of neuropsychiatric manifestations of SLE. Corticosteroid usage can cause psychiatric events, and differentiating corticosteroid induced psychiatric episodes from neuropsychiatric manifestations of SLE may be difficult. Depression is especially frequent in patients with SLE, and differentiating depression caused by possible psychological effects of the chronic disease from organic depression is required concurrently. Cranial Magnetic Resonance Imaging (MRI) and Quantitative Electroencephalography (QEEG) can be useful for detecting specific involvement of the central nervous system. The pediatrician, specialists and the mental health team may work together to help the child and his or her family throughout the course of the illness. The primary physician should consult with a child psychiatrist when psychiatric symptoms are seen in terms of the differential diagnosis and treatment.

Özet

Sistemik Lupus Eritematosus (SLE) otoimmün multisistemik bir hastalıktır ve merkezi sinir sistemi (MSS) SLE tarafından tutulan en yaygın sistemlerden biridir. Nörolojik tutulumu olan SLE hastalarında, psikoz, nöbet ve çeşitli bilişsel işlev bozuklukları gibi nöropsikiyatrik komplikasyonların bulunabildiği saptanmıştır. Nöropsikiyatrik SLE (NP-SLE) her tür duygulanım bozukluğuna yol açabilir. Psikiyatrik tutulum duygudurum labilitesi, elavasyon, irritabilite, depresyon ve psikoza eşlik edebilir. Tanı koymak, SLE’nin çok çeşitli olabilecek nöropsikiyatrik görünümleri nedeniyle zordur. Kortikosteroid kullanımı psikiyatrik durumlara neden olabilir ve kortikosteroide bağlı psikiyatrik belirtileri SLE’nin nöropsikiyatrik tutulumuna bağlı olan belirtilerinden ayırmak zor olabilir. SLE hastalarında depresyon, özellikle sıktır ve eş zamanlı olarak organik depresyonu kronik hastalığın olası psikolojik etkilerine bağlı depresyondan ayırmak gereklidir. Manyetik rezonans görüntüleme (MRG) ve Kantitatif Elektroensefalografi (QEEG) MSS’in özgül tutulumunu saptamada yararlı olabilir. Pediatristler, uzmanlar ve ruh sağlığı hekimleri, hastalığın gidişi boyunca çocuğa ve ailesine yardım etmek için birlikte çalışabilirler. Birincil hekim, psikiyatrik belirtiler görüldüğünde ayırıcı tanı ve tedavi yönünden bir çocuk psikiyatristi ile konsültasyonda bulunmalıdır.

🔖

Cite This Article

EMİROĞLU, F. İ., DEMİRGÖREN, B. S. (2008). Neropsychiatric aspects of systemic lupus erythematosus in children and adolescents. Nöropsikiyatri Arşivi, Cilt: 45 - Sayı: 3, 92–96. https://ajindex.com/articles/294451

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Hebra F, Kaposi M. On diseases of the Skin including the Exanthemata, vol 4. London, The New Sydenham Society, 1875
  2. West SG. Neuropsychiatric Lupus. Rheum Dis Clin North Am 1994; 20: 129-58
  3. Hanly JG. Evaluation of patients with CNS involvement in SLE. Bailiere’s Clin Rheumatol 1998; 12: 415-31
  4. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996; 156: 1337-44
  5. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 1985; 55: 87-98
  6. Esters D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971; 50: 85-95
  7. Karassa FB, Ioannidis JPA, Toulomi G et al. Risk factors for central nervous system involvement in systemic lupus erythematosus. Q J Med 2000; 93: 169-74
  8. West SG. Lupus and the central nervous system. Curr Opin Rheumatol 1996; 8: 408-14
  9. Wallace DJ, Metzger AL. Systemic lupus erythematosus and the nervous system. In: Wallace DJ, Hahn BH, editors. Dubois’ lupus erythematosus. Baltimore: William & Wilkins; 1997. p. 723-54
  10. Baca V, Lavalle C, Garcia R et al. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 1999; 26: 432-9
  11. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenculture. Case definitions for neuropsychiatric syndromes in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 599-608
  12. Mok CC, Lau CS, Wong RWS. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 766-71
  13. Baca V, Lavalle C, Garcia R et al. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 1999; 26: 432-9
  14. Silber TJ, Chatoor I, White PH. Psychiatric manifestations of systemic lupus erythematosus in children and adolescents. A review. Clin Pediatr (Phila). 1984; 23: 331-5
  15. Cassidy JT, Petty RE. (editors) Textbook of Pediatric Rheumatology, Systemic lupus erythematosus in Cassidy JT, Petty RE, Fourth Edn. 1997. p. 406-408, 429
  16. Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40
  17. Patten SB, Neutel CI. Corticos